Tenase and prothrombinase complexes (Tenase and Prothrombinase)

The tenase and prothrombinase complexes are multi-component enzymatic assemblies that play a central role in the blood coagulation cascade (Mann et al., 2003). The tenase complex, which exists in both intrinsic (Factor IXa and Factor VIIIa) and extrinsic (Factor VIIa and Tissue Factor) forms, is responsible for the proteolytic activation of Factor X into Factor Xa (Morita, 2005). Once formed, Factor Xa associates with Factor Va to form the prothrombinase complex, which catalyzes the conversion of prothrombin into thrombin, the key enzyme for fibrin clot formation (Krishnaswamy, 2013). Both complexes require the presence of calcium ions and a negatively charged phospholipid surface, typically provided by activated platelets, to achieve optimal catalytic efficiency (Nesheim et al., 1979). These complexes are major therapeutic targets for anticoagulants; for instance, direct oral anticoagulants like rivaroxaban and apixaban specifically inhibit the Factor Xa component of the prothrombinase complex (StatPearls, 2023). Dysregulation of these complexes is associated with various thromboembolic diseases, including deep vein thrombosis, pulmonary embolism, and stroke, while deficiencies in their components lead to bleeding disorders such as hemophilia (NIH, 2022).

Other names

Calcium- and phospholipid-dependent factor X and prothrombin activator complexesTenase complexProthrombinase complexFactor X activating complexProthrombin activating complexIntrinsic tenase (FIXa-FVIIIa-Ca2+-PL)Extrinsic tenase (FVIIa-TF-Ca2+-PL)Factor Xa-Va complex

Direct or indirect inhibition of the serine protease components (Factor Xa or Factor IXa) within the multi-protein complexes to prevent the downstream generation of thrombin.